1. Leaf, C. Why we're losing the war on cancer: and how to win it. Fortune 149, 77–92 (2004).
2. National Cancer Institute. Cancer Trends Progress Report
[online]
(2005).
3. Weiss, A. J. et al. Phase II study of 5-azacytidine in solid tumors. Cancer Treat. Rep. 61, 55–58 (1977).
4. Lomen, P. L., Khilanani, P. & Kessel, D. Phase I study using combination of hydroxyurea and 5-azacytidine (NSC-102816). Neoplasma 27, 101–106 (1980).
5. Lomen, P. L., Baker, L. H., Neil, G. L. & Samson, M. K. Phase I study of 5-azacytidine (NSC-102816) using 24-hour continuous infusion for 5 days. Cancer Chemother. Rep. 59, 1123–1126 (1975).